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Surgeon-modified fenestrated-branched stent
grafts to treat emergently ruptured and
symptomatic complex aortic aneurysms in
high-risk patients
Joseph J. Ricotta, II, MD, MS, and Nikolaos Tsilimparis, MD, Atlanta, Ga
Introduction: Fenestrated-branched stent grafts have been developed as a minimally invasive, endovascular alternative for
the treatment of complex aortic aneurysms in high-risk patients. However, the manufacture of these devices can take as
long as 6 to 12 weeks, and therefore, they cannot be used to treat aortic emergencies. We reviewed our experience with
surgeon-modified, fenestrated-branched stent grafts (sm-FBSGs) in high-risk patients who presented as emergencies with
ruptured or symptomatic complex aortic aneurysms.
Methods: All patients treated with sm-FBSGs at our institution were retrospectively reviewed. Patients presenting with
acute symptoms or an emergency indication for repair were analyzed.
Results: Twelve high-risk patients (nine men), of which seven were at American Society of Anesthesiologists class 4 and
five were at class 3, presented with seven symptomatic and five ruptured aortic aneurysms. Mean age was 71 years (range,
52-86 years), and mean maximal aneurysm size was 8.1 cm (range, 5-12 cm). Six patients (50%) had prior aortic surgery
or a hostile abdomen. Relevant comorbidities included coronary disease in all 12 patients, and seven (58%) had an ejection
fraction <35%. Nine patients (75%) had severe pulmonary dysfunction. Four aneurysms were pararenal, and eight were
thoracoabdominal (two type II, three type III, and three type IV). An average of three visceral vessels (range, 2-4) were
treated per patient, with 35 branches targeted. Endografts were successfully implanted in all patients. There was no
paraplegia or intraoperative death. One patient (8.3%) died of subarachnoid hemorrhage <30 days. Reintervention was
necessary in two patients, for a type 3 endoleak and for evacuation of a retroperitoneal hematoma.Morbidity included one
myocardial infarction, and two patients each with transient respiratory failure and transient renal insufficiency not
requiring dialysis. Mean postoperative length of stay was 4 days in the intensive care unit and 8 days in the hospital. At
a mean follow-up of 9 months (range, 3-18 months), two patients died of non–aneurysm-related causes. Branch vessel
patency was 100%. No late reinterventions were necessary. No type I or III endoleaks occurred. One type II endoleak is
under observation.
Conclusions: Sm-FBSG may play an important role in the treatment of select patients with symptomatic or ruptured
complex aortic aneurysms who are at prohibitive risk for open surgery and in whom endovascular repair cannot be delayed
to allow implantation of a custom-made commercial device. Until an off-the-shelf fenestrated-branched device is created
that does not require a prolonged waiting period, this may be the best option to treat patients with symptomatic or
ruptured complex aneurysms that are at excessively high surgical risk. ( J Vasc Surg 2012;56:1535-43.)
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mOpen surgery for complex aneurysms of the abdominal
aorta (AAAs), including thoracoabdominal aortic aneu-
rysms (TAAAs), has greatly improved in recent decades to
provide adequatemanagement for patients with good func-
tional results and reduced perioperative morbidity and
mortality.1,2 However, despite much advancement in pre-
operative evaluation and perioperative care of patients with
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http://dx.doi.org/10.1016/j.jvs.2012.05.096AAA, open surgical repair of TAAAs remains a formidable
hallenge for the vascular surgeon. A recent meta-analysis
f the world literature on open TAAA repair, which in-
luded 7833 patients who underwent open surgical repair
f TAAA between the 2000 and 2010, found the overall
isk of death30 days was 7% and in-hospital mortality was
0%.3 The 30-day mortality was 5% for elective cases, with
ignificant associated morbidity ranging from a 7.5% inci-
ence of spinal cord ischemia to a 19% rate of renal failure
nd a 36% rate of pulmonary dysfunction. The 30-day
ortality for open repair of ruptured TAAA has been
eported as high as 40%, with an average of 19% in this
eta-analysis.
These data clearly demonstrate the high morbidity and
ortality of the open procedure, particularly in the urgent
r emergency setting, even in well-selected patients consid-
red to be at low or moderate risk for surgery. As a
onsequence, many high-risk patients with significant co-
orbidities will be denied elective open surgery. Neverthe-ess, even these high-risk patients may present acutely with
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requires urgent repair.
Endovascular aneurysm repair (EVAR) has been shown
to be effective in treating uncomplicated infrarenal and
thoracic aneurysms in the elective4,5 and urgent settings,6
yet experience with this technology in complex conditions
is limited. Fenestrated and branched endografts have been
developed as a minimally invasive, total endovascular alter-
native for the treatment of complex aortic aneurysms in
high-risk patients.7 However, these devices must be cus-
tom-made to fit the specific anatomic requirements of each
patient, and the manufacture of these devices can take as
long as 6 to 12 weeks. Restricted access to investigational
devices and delays for device customization limit treatment
with these endografts to a small group of patients with
relatively stable aneurysms. Patients who present as emer-
gencies with ruptured or symptomatic complex AAAs and
TAAAs cannot be treated with the current fenestrated-
branched endograft technology because of the degree of
customization required to treat each individual patient.
We are often confronted with the complex dilemma of
how best to treat patients who are unfit for open repair or
aortic debranching procedures, who present as an emergency
with symptomatic or ruptured complex aortic aneurysms, and
who cannot wait for the creation of a custom-made fenestrated-
branched endograft. In these circumstances, we have used
surgeon-modified, fenestrated and branched endografts
(sm-FBSGs) by modifying commercially available aortic
endovascular stent grafts with reinforced fenestrations as
well as cuffed branches. In our opinion, sm-FBSGs with
branches for the visceral vessels and a treatment window of
1 to 2 hours is a viable therapeutic alternative for high-risk
patients unfit for open surgery who require urgent treat-
ment. In this report, we review our experience with urgent
and emergency management of patients with complex
AAAs and TAAAs using a total endovascular technique
with sm-FBSGs.
METHODS
Study design. This was a retrospective analysis of pa-
tients with complex AAAs and TAAAs who presented with
symptomatic aneurysms or contained ruptures and were
treated with sm-FBSGs by the same primary operator (J.R.)
between August 2010 and January 2012. Primary study
end points were procedural technical success, 30-day sur-
vival, 30-day reintervention, and complications. Secondary
end points were long-term survival, stent patency, and
reintervention.
All patients who were candidates to undergo fenes-
trated repair of their complex aneurysm with the use of an
sm-FBSG were informed that the use of the stent grafts was
not according to instructions for use and had an extensive
discussion with the primary surgeon with respect to the
risks of graft modification, durability of the repair, safety,
and efficacy of the procedure. The study resulting in this
report was performed under an Institutional Review Board
protocol and subsequently led to approval of a physician-
sponsored investigational device exemption (IDE) by the fl.S. Food and Drug Administration for pararenal aneu-
ysms and TAAA (MO-dified STE-nt GRA-ft [MO-
TEGRA] Trial, IDE: G120071).
Technique. Modification of a commercially available
ortic stent graft was performed to create the fenestrations
ccording to the patient’s anatomy. The number of fenes-
rations or scallops ranged from one to five and the graft
sed for modification was a TX2 Zenith (Cook, Blooming-
on, Ind) thoracic tube graft or an AAA Zenith (Cook) or
AA Endurant (Medtronic CardioVascular, Santa Rosa,
alif) bifurcated abdominal graft, depending on the extent
f the aneurysm.
Preoperative measurements were performed on an ad-
anced iNtuition workstation (Terarecon Inc, San Mateo,
alif) using centerline of flow analysis. Fenestrations were
ormally constructed to be 6  8 mm in size and located
etween the stent struts. Each fenestration was reinforced
y a radiopaque wire to prevent tearing or fraying of the
raft fabric and to allow intraoperative orientation under
uoroscopy.
Access from both femoral arteries was always obtained.
hen three or more branches were planned, left brachial
ccess was established. We do not routinely use right bra-
hial access.
Typically in the setting of a four-vessel sm-FBSG, access
o both renal and superior mesenteric artery (SMA)
ranches is achieved from the right femoral access, and the
eft femoral approach is used for the introduction of the
ain stent graft. The celiac artery is typically accessed from
he left brachial artery.
Bridging of the fenestrations to the aortic branch ves-
els was performed by placing iCAST balloon-expandable
tent grafts (AtriumMedical Corp, Hudson, NH) through
he fenestrations and into the target branch vessels. These
tent grafts were then flared proximally with an oversized
alloon to create a seal with the main aortic endograft and
revent dislodgement of the branch stents. Additional sup-
ortive bare metal stents were used on demand. The tech-
ique has been previously described in detail.8,9
Prophylactic spinal drainage is strongly considered in
ur practice when one or more of the following apply: (1)
overage of 20 cm of the thoracic aorta is planned, (2)
rior infrarenal aorta repair had taken place, (3) in case of
cclusion of a hypogastric or vertebral arteries, and (4)
hen coverage of the subclavian artery is planned.
Definitions. Complex AAAs were defined as those
hat were located in the paravisceral aorta and involved the
enal or mesenteric arteries. Patients were classified as
ymptomatic if the aneurysm was tender on palpation or if
hey presented with new-onset abdominal or back pain and
ther potential intra-abdominal andmusculoskeletal causes
ere excluded on clinical examination and by computed
omography (CT) scan. In addition, a change in the CT
can with respect to aneurysm size, morphology, or throm-
us distribution had to be present compared with a previ-
us CT scan, if available. Contained ruptures were ruptures
nto the surrounding tissue without free intra-abdominal
uid documented on the CT scan.
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Volume 56, Number 6 Ricotta and Tsilimparis 1537Patient selection. Only selected patients in an acute
setting were candidates for sm-FBSG. For patients in good
general condition without significant comorbidities, open
repair was performed. High-risk patients with comorbidi-
ties prohibitive for open surgery were considered candi-
dates for total EVAR. These included those with a known
recent myocardial infarction or reduced cardiac ejection
fraction (EF) (35%), severe pulmonary dysfunction
(forced expiratory volume in 1 second of 1 L) or requir-
ing oxygen replacement therapy, and those with a hostile
abdomen as a result of multiple prior abdominal and aortic
surgeries or active enterocutaneous fistulae or ostomy. The
management protocol enrolled hemodynamically stable pa-
tients whowere deemed to have a treatment window of 1 to
2 hours, according to clinical assessment and evaluation of
the CT scans.
During the same period, 23 patients underwent open
repair of a symptomatic or ruptured TAAA. Only one
was treated as an emergency for a contained rupture.
This study focuses only on results in the emergency
setting. We did not refuse any patients who presented as
emergencies. This, of course, is different in our elective
practice.
Statistical analysis. Descriptive data analysis was per-
formed using SPSS 19.0 software (IBM-SPSS, Chicago,
Ill). Categoric data are described using absolute numbers
and percentage of prevalence (%) in the study cohort and
continuous variables are presented as means (range). Cate-
goric variables were compared by use of the 2 test or Fisher
exact test, and independent two-sample t-tests were used
for continuous variables or the Wilcoxon rank sum test for
Fig 1. A, A computed tomography (CT) scan demonst
aneurysm (TAAA) (arrow). B, Centerline of flow anal
preoperative measurements made to plan construction
modified Zenith TX2 endograft with four reinforced fennonparametric data. cESULTS
Between August 2010 and January 2012, 12 patients
nine men) underwent sm-FBSG repair of their symptomatic
r ruptured complex aortic aneurysms. The indication to
perate in these 12 patients was acute onset of symptoms in
even and aneurysm rupture in five (Figs 1-3).
Patient characteristics. Patient characteristics are pre-
ented in Table I. Patients were a mean age of 71 years
range, 52-86 years). Seven patients were classified as
merican Anesthesiologist Association (ASA) risk class 4
nd five as ASA 3. The mean Society for Vascular Surgery
SVS) cardiac, respiratory, renal, hypertension, and age
cores were 8, 4, 2, 3, and 2, respectively, with a mean total
VS score of 19 (range, 7-27). According to the Eagle
linical criteria, the mean number of risk factors was 2.1
range, 0-4). The cardiac EF was 35% in seven patients
58%), with a mean EF of 40% (range, 20%-65%). One
atient was on the waiting list to receive a heart transplant
nd another patient had undergone prior attempted open
epair of his TAAA that was aborted after a myocardial
nfarction occurred during induction of anesthesia. Nine
atients (75%) had severe chronic obstructive pulmonary
isease, and four (33%) of these required home oxygen. Six
atients (50%) had prior aortic surgery or a hostile abdo-
en.
Aneurysm and technical characteristics. Aneurysm
nd technical characteristics are reported in Table II. The
ean maximal aneurysm size was 8.1 cm (range, 4.9-12.1
m). Four aneurysms were pararenal and eight were TAAA
two type I, three type III, and three type IV).
A total 35 vessels were targeted in the 12 patients,
contained rupture of a type IV thoracoabdominal aortic
econstruction of a CT scan demonstrates rupture and
four-vessel fenestrated-branched device. C, Surgeon-
ions to revascularize the visceral vessels.rates
ysis r
of aomprising 33 fenestrated branches and two scallops. No
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The celiac axis was targeted in seven patients (58%), the
SMA in 10 (83%), the right renal artery in 10 (73%), and
the left renal artery in eight (67%). Both scallops were
performed for the SMA in the setting of a pararenal aneu-
rysm, requiring fenestrations of the renal arteries.
No visceral arteries were covered when patent preoper-
atively. However, two patients had an occluded celiac artery
preoperatively, and one patient had an atrophic, nonfunc-
tioning left kidney. Another patient was receiving long-
term dialysis. The respective branches in these patients were
overstented without revascularization.
Adjunctive stents were occasionally required to support
the iCAST stent or straighten a kinked portion of the
iCAST or branch artery. These included two Smart stents
(Cordis Corp, Bridgewater, NJ) for SMAs, one for a celiac
artery and one E-Luminexx Vascular Stent (C. R. Bard,
Murray Hill, NJ) to a left renal branch. On further
follow-up, no relevant stenoses or kinks requiring inter-
vention were observed in any of the postoperatively
patent branches.
Adjuvant procedures included use of an iliac conduit
through retroperitoneal access in two patients (17%), and
an endoconduit in one patient (8%). A lumbar spinal drain
to remove cerebrospinal fluid was used in six of eight TAAA
Fig 2. A, An intraoperative angiogram demonstrates
fluoroscopy shows all four fenestrations and target viscer
diameter-reducing ties and complete deployment of t
successful repair of ruptured type IV thoracoabdominal ao
in place in the target vessels and no evidence of endoleakrepairs. nTechnical results. Successful aneurysm exclusion was
chieved in all patients. Technical success of revascularizing
ll target vessels with branch stents was achieved in 35 of 36
ranches. One branch to a right renal artery could not be
laced because of misalignment of the fenestration to the
arget vessel. One intraoperative iliac rupture occurred in a
atient with severely calcified iliac vessels and was managed
y implantation of two Viabahn stent grafts (W. L. Gore
nd Associates, Flagstaff, Ariz).
The mean procedural time was 391 minutes (range,
0-720 minutes), including device modification time. The
ean time for device modification was 105minutes (range,
0-180 minutes). The mean volume of contrast agent used
as 209 mL (range, 60-390 mL), and mean fluoroscopy
ime was 136 minutes (range, 35-316 minutes). Mean
stimated blood loss was 936 mL (range, 300-2600 mL).
Outcome at 30 days. The 30-day or in-hospital sur-
ival was 92%. One patient died of an intracranial hemor-
hage on postoperative day 10. This patient had a known
erebral aneurysm that had been previously treated preop-
ratively with coil embolization. She had a type II TAAA
hat required treatment with a five-vessel FBSG with
ranches to the left subclavian, celiac, superior mesenteric,
nd both renal arteries. There were no occurrences of spinal
ord ischemia with transient or permanent paraplegia and
re of the thoracoabdominal aorta. B, Intraoperative
sels cannulated with sheaths and wires before release of
nestrated endograft. C, Completion angiogram after
neurysm (TAAA) shows patency of all four branch stentsruptu
al ves
he fe
rtic ao other cerebrovascular events.
o
E
o
c
a
r
i
c
w
m
t
t
p
n
b
o
d
d
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 6 Ricotta and Tsilimparis 1539One patient (8%) experienced an asymptomatic tro-
ponin I elevation and a non-ST elevation myocardial infarc-
tion in the early postoperative period. Two patients (17%)
required prolonged intubation or reintubation for respira-
tory dysfunction, but no tracheostomy was required. For all
12 patients in this study, the mean preoperative creatinine
value was 1.2 mg/dL and the mean postoperative value was
1.7mg/dL.However, two patients (17%) had transient acute
renal failure postoperatively with elevated creatinine levels but
did not require dialysis. The preoperative to postoperative rise
in creatinine levels was from 1.1 to 3.3 mg/dL in one patient
and from 1.8 to 4.2 mg/dL in the second patient. Both
patients continued to produce urine during their hospital stay,
and their creatinine levels returned to baseline by the time of
their follow-up visits. At follow-up, they underwent our stan-
dard imaging protocol, which consists of a CT angiography of
the chest, abdomen, and pelvis, and duplex ultrasound imag-
ing of the branch stents.
Other complications included one patient with a retro-
peritoneal hematoma, which required a return to the oper-
Fig 3. A three-dimensional computed tomography (CT
ruptured visceral aorta and (B) at 6 months, demonstrat
vessels.ating room and evacuation after conduit placement, and hne patient with decompensated congestive heart failure.
arly reinterventions were necessary in two patients (14%),
ne for evacuation of a retroperitoneal hematoma after
onduit placement to the right common iliac artery, and
nother for occlusion of the fenestration of a misaligned
enal artery with an Amplatzer ductal occluder (AGAMed-
cal, Corp, Plymouth, Minn). Both interventions were suc-
essful, with the second achieving seal of the fenestration
ith sacrifice of the renal artery. In the patient with the
isaligned renal artery, several maneuvers and successive
ries were performed to cannulate the artery, resulting in
he use of 390 mL of contrast agent.
The highest blood loss in this series occurred in the
atient who required reoperation because of a retroperito-
eal hematoma after conduit placement. The estimated
lood loss of 2600mL represents the cumulative blood loss
f both procedures.
The mean length of stay in the intensive care unit was 4
ays (range, 1-19 days) and the total in-hospital stay was 8
ays (range, 3-16 days). Nine patients were discharged to
iography is shown (A) preoperatively in a patient with
o endoleak and patent branch stents to all four visceral) ang
ing nome and three to a subacute nursing facility.
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December 20121540 Ricotta and TsilimparisFollow-up. All patients were followed up with clinical
examination, duplex ultrasound imaging of the visceral
stents, contrast-enhanced CT of the thoracoabdominal
Table I. Epidemiologic characteristics of the cohort
Variable
No. (%)
(n  12)
Coronary artery disease 12 (100)
Previous myocardial infarction 8 (67)
Chronic heart failure 8 (67)
Previous interventions
CABG 7 (58)
PTCA  stent 8 (67)
Aortic surgery 6 (50)
Abdominal surgery 6 (50)
Ejection fraction 35% 7 (58)
Hypertension 12 (100)
Hyperlipidemia 12 (100)
Smoking 12 (100)
Active smoker 5 (42)
COPD 9 (75)
Home oxygen/steroids 4 (33)
Diabetes mellitus 2 (25)
Renal insufficiency (creatinine 1.5 mg/dL) 3 (25)
Terminal renal insufficiency 1 (8)
Hostile abdomen 6 (50)
Peripheral arterial disease 3 (25)
Previous cerebrovascular event 1 (8)
CABG,Coronary artery bypass grafting;COPD, chronic obstructive pulmo-
nary disease; PTCA, percutaneous transluminal coronary angioplasty.
Table II. Aneurysm characteristics and type of repair
Characteristics Value
Patients, No. 12
Symptoms, No. (%)
Symptomatic 7 (58)
Contained rupture 5 (42)
Aneurysm type, No. (%)
Pararenal 4 (33)
TAAA type
I 0 (0)
II 2 (17)
III 3 (25)
IV 3 (25)
Devices used, No
Renu RX1a 1
Zenith TX2a 12
Zenith bifurcated AAAa 3
Endurantb 1
Vessels revascularized, No. 35
Mean (range) per patient 2.9 (1-4)
Fenestrated branches, No. (%) 33 (94)
Scallops, No. (%) 2 (6)
Celiac artery, No. (%) 7 (58)
SMA, No. (%) 10 (83)
Right renal artery, No. (%) 10 (83)
Left renal artery, No. (%) 8 (67)
AAA, Abdominal aortic aneurysm; SMA, superior mesenteric artery;
TAAA, thoracoabdominal aortic aneurysm.
aCook, Bloomington, Ind.
bMedtronic CardioVascular, Santa Rosa, Calif.aorta, and control of the creatinine value at 1 and 6 months tnd every 6 months thereafter. The mean follow-up was 9
onths (range, 3-18 months). Two patients died during
ollow-up of causes unrelated to the aneurysm repair. One
atient died of cardiac causes after sustaining a cardiac
nfarct at 4 months. The second patient died 5months after
epair of her ruptured type III TAAA from gradual deteri-
ration of her baseline poor medical condition (ASA class
, severe chronic obstructive pulmonary disease, coronary
rtery disease with prior myocardial infarction and coronary
rtery bypass grafting, EF of 20%, mild renal insufficiency,
VS score of 21). Follow-up assessment with duplex ultra-
ound imaging and CT scan showed the patient had patent
isceral and renal branch stents and exclusion of the aneu-
ysm. However, gradual deterioration of her overall health
nd mental status led subsequently to admission to hospice
are, where she died.
No late reinterventions were required, and all branches
atent at the conclusion of the procedure remained patent
n follow-up (100%). The two deaths during follow-up
ccurred in patients with contained ruptures. On follow-up
T scans, seven aneurysms showed regression of the max-
mal diameter5mm (64%) and five remained unchanged.
he mean diameter regression of the seven regressing an-
urysms was 12mm (range, 6-22 mm). One persistent type
I endoleak from the inferior mesenteric artery was not
ssociated with sac enlargement and is under observation at
ostoperative month 6.
ISCUSSION
This study presents the largest reported series to date of
igh-risk patients treated in the emergency setting with
m-FBSG for complex AAAs and TAAAs. All 12 patients
ad risk factors prohibitive for open surgery, as reflected by
mean SVS score of 19 and a mean Eagle score of 2.1, and
ould have been denied elective or even emergency repair.
evertheless, these high-risk patients benefited from this
otal endovascular approach to achieve a 30-day survival of
2% compared with mortality rate of open repair for rup-
ured complex aneurysm, which has been reported as high
s 40% to 80%.3,10 The only death in this series resulted
rom an intracranial subarachnoid hemorrhage in a patient
ho had previously undergone coiling of a cerebral aneu-
ysm. That 75% of discharged patients were able to return
o their family environment directly after their hospital stay
s a measure of the quality of life that was preserved in these
atients postoperatively.
The available options to treat high-risk patients with
omplex aortic aneurysms in an acute setting are limited.
pen surgical repair should represent the last option for
hese high-risk patients given that elective repair of TAAA
n low-risk to medium-risk patients is associated with a 5%
ortality that increases to 19% (range, 13%-40%) for emer-
ency cases.3 Several published reviews of pararenal aneu-
ysms report that suprarenal clamping is associated with a
ortality rate of 3% to 6% for elective cases as well as a
ew-onset of dialysis rate of another 3% to 5%, with 18% of
he patients experiencing postoperative renal dysfunc-
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Volume 56, Number 6 Ricotta and Tsilimparis 1541tion.10,11 In the emergency setting, mortality is as high as
40% to 80%.10,12
Hybrid procedures with debranching techniques of the
abdominal aorta and stent graft placement over the visceral
aortic segment have been associated with an in-hospital
mortality rate of 12.8%, spinal cord ischemia of 7.5%, and
renal failure of 8.8%.13 Again, wemust emphasize that most
of these results for open surgery are in patients considered
at good or moderate risk. This must be contrasted with the
results for the patients in this study who were all at high risk
for open surgery.
EVAR with the chimney technique (Ch-EVAR) for
urgent complex aortic pathologies has been described with
progressive frequency during the last years as a bailout
procedure. Repair of juxtarenal or thoracoabdominal aneu-
rysms with visceral vessel revascularization in patients with
acute pathologies has been reported.14-17 These reports
focus mostly in the feasibility of the procedure, without
reporting long-term results.14,16,18,19 Ch-EVAR certainly
represents a useful bailout technique in urgent cases but
does not reproduce an anatomic aneurysm repair, and the
durability of this technique for branch patency and deficits
of visceral perfusion remains unknown.
The value of FBSGs in the management of high-risk
patients with TAAA unfit for open surgery is indisputable.
Lower perioperative morbidity andmortality with excellent
midterm and long-term results have been demonstrat-
ed.20-23 The major drawback of this procedure at the
moment is the lack of a standardized off-the-shelf graft.
Custom-made FBSGs are patient-tailored, and an interval
of 6 to 12 weeks is required between measurement and
delivery of the graft from the manufacturer, thereby pre-
venting the treatment of patients with urgent aortic pathol-
ogies.
Recently, Sweet et al24 retrospectively evaluated the CT
scans in 66 patients with TAAA and concluded that a
standardized, off-the-shelf, multibranched stent graft was
applicable in 88% of TAAA cases that would otherwise have
been treated using customized stent grafts. The concept of
a standardized, off-the-shelf, multibranched stent graft is
exciting. However, the use of a standardized graft could
compromise the principle of perfect alignment of the graft
to the target vessels, with unknown results on long-term
branch patency. The routine use of plugs to occlude unused
branches in a standardized graft could potentially lead to
higher risk of endoleaks, and the efficacy of these grafts in
the emergency setting is unknown.
Stent grafts for endovascular repair of complex aneu-
rysms are currently fenestrated, typically with a reinforce-
ment around the fenestration, or precuffed with a cuff
(“branch”) coming off the origin of the fenestrations. The
cuffs may be helical or caudally or cranially oriented.
The off-the-shelf devices currently in the pipeline aim
for juxtarenal and suprarenal aneurysms (fenestrated de-
sign) as well as thoracoabdominal aneurysms (branched
design). Although these current designs can theoretically
treat 50% to 90% of these pathologies, those anatomies
remaining outside the current design limits will still require pustom devices.24,25 The typical design of these off-the-
helf grafts includes two fenestrations (or branches) to the
enal arteries and a scallop for the SMA.
Preliminary results of the Zenith off-the-shelf device
Cook) with preloaded wires through the fenestrations to
acilitate easier cannulation were encouraging.26 Similar
tent grafts have been developed by different companies,
ncluding the Ventana fenestrated off-the-shelf stent graft
Endologix, Irvine, Calif),27 the fenestrated Anaconda
Vascutek, Inchinnan, UK),28 and the Medtronic abdom-
nal branch stent graft (Medtronic CardioVascular, Santa
osa, Calif).
Nevertheless, until industry develops a standardized,
ff-the-shelf, multibranched stent graft that can be used in
rgent and emergency situations, the option of an sm-
BSG appears to be the most effective solution, combining
1) the good long-term results of fenestrated repair, (2)
eal-time construction of a graft 100% tailored to patient’s
natomy, (3) the ability to modify the endograft and have it
eady for use within 1 to 2 hours, and (4) the potential of
ower cost compared with a customized fenestrated graft.
Among the restrictions of sm-FBSG in urgent pathol-
gies are that they can only be applied in patients who are
emodynamically stable. A thin-slice CT scan and advanced
easuring software has to be present to extract exact mea-
urements of the aneurysm before proceeding with modi-
cation of the stent graft. Between obtaining the CT scan
nd definite therapy of the aneurysm, a window of 1 to 2
ours has to be available to modify the endograft. In most
ases, this time coincides with the preparation of the patient
rom the anesthesiology team and bilateral femoral artery
xposure and access. As the graft is being prepared by the
rimary surgeon with the help of a junior resident or nurse
n the back table, the assistant surgeon can work in parallel
n the surgical exposure of the access vessels (femoral
rteries and sometimes left brachial artery).
In this series, only fenestrated branches and no direc-
ional branches were used for the treatment of TAAA.
lthough some authors argue that the connection between
he fenestration and the ostium of the target vessel is
ssociated with more instability in the setting of TAAA, no
ata exist to support a better long-term outcome or dura-
ility when directional branches are used instead of fenes-
rations, and none of the supporters of directional branches
ave, to the best of our knowledge, published results
avoring directional vs fenestrated branches for TAAA so
ar.
Construction of a directional branch is an option for
AAA in elective cases. However, directional branches take
onger to construct than fenestrated branches, and there-
ore in an urgent setting where time is of the essence, we
refer to use fenestrated branches to get patients into and
ut of the operating room as soon as possible.
Limitations of our study include its retrospective char-
cter as well as lack of a control group undergoing open
epair or Ch-EVAR. Owing to the restricted number of
atients, statistical analysis was not able to provide any
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December 20121542 Ricotta and Tsilimparisfurther information regarding subgroups at high risk for
complications or death 30 days.
CONCLUSIONS
Sm-FBSGs may play an important role in the treatment
of selected patients with symptomatic or ruptured aneu-
rysms who are at prohibitive risk for open surgery and in
whom EVAR cannot be delayed to allow implantation of a
custom-made commercial device. Until commercially avail-
able fenestrated-branched devices become more widely
disseminated, and an off-the-shelf device is created that
does not require a prolonged waiting period, this may be
the best option to treat patients with symptomatic or
ruptured complex aneurysms who are at excessively high
surgical risk.
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